Normal view MARC view ISBD view

Multi-Targeted Approach for Dual Inhibition of CCR5 and CXCR4 as Novel HIV-1 Entry Inhibitors: Design and Synthesis of Novel RHO Kinase II Inhibitors as Anti-Cancer Agents

By:

Material type: Film

FilmPublication details: Ahmadabad Institute of Pharmacy, Nirma University 2019Description: 78pSubject(s):

DDC classification:

Online resources:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode	Item holds
Dissertation	NIMA Knowledge Centre	Reference	615.19 SHA (Browse shelf(Opens below))	Not For Loan		PDR00592
CD/DVD	NIMA Knowledge Centre	Reference	615.19 SHA (Browse shelf(Opens below))	Not For Loan		PDR00592-1

Total holds: 0

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	615.19 SHA Molecular Docking Synthesis and Pharmacological Screening of Peroxisome Proliferator -activated receptor (PPAR) Y Agonists for treatment of type 2 Diabetes	615.19 SHA Molecular Docking Synthesis and Pharmacological Screening of Peroxisome Proliferator -activated receptor (PPAR) Y Agonists for treatment of type 2 Diabetes	615.19 SHA Abdominal Koch’s Disease	615.19 SHA Multi-Targeted Approach for Dual Inhibition of CCR5 and CXCR4 as Novel HIV-1 Entry Inhibitors: Design and Synthesis of Novel RHO Kinase II Inhibitors as Anti-Cancer Agents	615.19 SHA Multi-Targeted Approach for Dual Inhibition of CCR5 and CXCR4 as Novel HIV-1 Entry Inhibitors: Design and Synthesis of Novel RHO Kinase II Inhibitors as Anti-Cancer Agents	615.19 SHA Ecotoxicology of Organohalides: A Review on Effects and Mitigation for Sustainability in Pharmaceutical Industry	615.19 SHA Regulatory Aspects of Biologics In India, USA And Europe	Next

Guided by Dr. Jignasa Savjani

There are no comments on this title.

to post a comment.